{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Determine affinity for human NKi receptor in radioligand binding studies (Assay 1); select compounds with IC50 \u2264 10nM, preferably IC50 < 2nM, especially IC50 < 1nM.\n* Determine ability of compounds to penetrate CNS by their ability to inhibit foot tapping in gerbils induced by central injection of an NKi agonist (Assay 2); select compounds that inhibit foot tapping with ID50 < 3mg/kg i.v., and preferably ID50 \u2264 1mg/kg i.v. when administered immediately prior to central NKi agonist challenge, or ID50 \u2264 30mg/kg p.o., and preferably ID50 \u2264 10mg/kg p.o. 1 hour prior to challenge,\n* Determine central duration of action of compounds in gerbil foot tapping assay following intravenous administration 24 hours prior to central NKi agonist challenge; select compounds showing < 2-fold loss of potency compared with ID50 determined in step (ii) above with the proviso that ID50 \u2264 10mg/kg i.v., and preferably < 1mg/kg i.v. after 24 hour pre-treatment.\n* Determine oral bioavailability of compounds by pharmacokinetic analysis, activity in gerbil foot tapping assay following oral administration and/or by ability to inhibit cisplatin-induced emesis in ferrets (Assay 3); select compounds with ID90 \u2264 3mg/kg p.o., and preferably \n* In an alternative method, the NK-1 receptor antagonist is administered orally, 1 hour prior to GR73632 challenge, wherein the foot- tapping over a period of five minutes following recovery from anaesthesia is inhibited with an ID50 30mg/kg, and preferably with an ID50\u226410mg/kg.\n* Essentially, a vocalisation response in guinea-pig pups is induced by isolation from their mothers and littermates, which response is attenuated when a CNS-penetrant NK-1 receptor antagonist is administered subcutaneously 30 minutes prior to isolation, wherein vocalisations during the first 15 minutes of isolation are attenuated with an ID50<20mg/kg, preferably with an ID50\u226410mg/kg, and especially with an ID50\u22641mg/kg.\n* In an alternative method, the NK-1 receptor antagonist is administered orally, 4 hours prior to isolation, wherein vocalisations during the first 15 minutes of isolation are attenuated with an ID50\u226420mg/kg, preferably with an ID50\u226410mg/kg, and especially with an ID50\u22641mg/kg."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human NKi receptor", "binding_metric": "IC50", "value": "\u2264 10nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human NKi receptor", "binding_metric": "IC50", "value": "< 2nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human NKi receptor", "binding_metric": "IC50", "value": "< 1nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "< 3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "\u2264 1mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "\u2264 30mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "\u2264 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "< 2-fold", "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "\u2264 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID50", "value": "< 1mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "ID90", "value": "\u2264 3mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "30mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "< 20mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 1mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 20mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 10mg/kg", "unit": "mg/kg", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "NK-1 receptor", "binding_metric": "ID50", "value": "\u2264 1mg/kg", "unit": "mg/kg", "is_logarithmic": false}]}
